Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -0.27 is 70% above its 5-year average of -0.90, near the high end of its 5-year range (-1.33–-0.27).
64.00% above its 12-month average of -0.75.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.04.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 22 comparable quarters.
EARNINGS PER SHARE (EPS)
-0.27
EARNINGS PER SHARE (EPS) AVG TTM
-0.75
EARNINGS PER SHARE (EPS) AVG 3Y
-1.03
EARNINGS PER SHARE (EPS) AVG 5Y
-0.90
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+64.00%
CURRENT VS 3Y AVG
+73.72%
CURRENT VS 5Y AVG
+69.89%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Rani Therapeutics Holdings, Inc.
Market Cap
$54.14M
Earnings Per Share (EPS)
-0.27
TTM Avg
-0.75
3Y Avg
-1.03
5Y Avg
-0.90
Market Cap
$53.70M
Earnings Per Share (EPS)
-1.00
TTM Avg
-1.43
3Y Avg
-2.38
5Y Avg
-2.90
Market Cap
$55.25M
Earnings Per Share (EPS)
-0.39
TTM Avg
-0.75
3Y Avg
-0.80
5Y Avg
-0.90
Market Cap
$52.83M
Earnings Per Share (EPS)
-0.35
TTM Avg
-0.57
3Y Avg
-0.69
5Y Avg
-0.62
Market Cap
$52.60M
Earnings Per Share (EPS)
N/A
TTM Avg
-0.08
3Y Avg
0.02
5Y Avg
0.04
Market Cap
$56.02M
Earnings Per Share (EPS)
N/A
TTM Avg
-0.18
3Y Avg
-0.24
5Y Avg
-0.27
Market Cap
$51.99M
Earnings Per Share (EPS)
N/A
TTM Avg
-7.29
3Y Avg
-67.66
5Y Avg
-178.24
Market Cap
$51.88M
Earnings Per Share (EPS)
-5.21
TTM Avg
-25.08
3Y Avg
-23.14
5Y Avg
-19.79
Market Cap
$57.01M
Earnings Per Share (EPS)
N/A
TTM Avg
-0.64
3Y Avg
-4.21
5Y Avg
-9.38
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Rani Therapeutics Holdings, Inc. (RANI) | $54.14M | -0.27 | -0.75 | -1.03 | -0.90 |
| NOMAD Power Solutions, Inc. (NMAD)vs › | $53.70M | -1.00 | -1.43 | -2.38 | -2.90 |
| Aldeyra The (ALDX)vs › | $55.25M | -0.39 | -0.75 | -0.80 | -0.90 |
| Spectral AI, Inc. (MDAI)vs › | $52.83M | -0.35 | -0.57 | -0.69 | -0.62 |
| Zhengye Biotechnology Holding Limited (ZYBT)vs › | $52.60M | N/A | -0.08 | 0.02 | 0.04 |
| OKYO Pharma Limited (OKYO)vs › | $56.02M | N/A | -0.18 | -0.24 | -0.27 |
| Eloxx Pharmaceuticals, Inc. (ELOX)vs › | $51.99M | N/A | -7.29 | -67.66 | -178.24 |
| ImageneBio Inc (IMA)vs › | $51.88M | -5.21 | -25.08 | -23.14 | -19.79 |
| Connect Biopharma Holdings Limited (CNTB)vs › | $57.01M | N/A | -0.64 | -4.21 | -9.38 |
| eXoZymes, Inc. (EXOZ)vs › | $51.23M | -1.20 | -0.91 | -0.56 | -0.48 |
Trailing EPS (TTM)
$-0.27
Forward EPS (Est.)
$-0.17
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -0.45 |
| 2024-12-31 | -1.05 |
| 2023-12-31 | -1.33 |
| 2022-12-31 | -1.28 |
| 2021-12-31 | -0.42 |
| 2020-12-31 | -0.85 |
| 2019-12-31 | -1.35 |
